Clinical Trial Update: Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a topical formulation aimed at treating and preventing Raynaud's phenomenon symptoms; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon

Drugs mentioned

• Topical formulation (unnamed)

Snippet

Sponsor: MediQuest Therapeutics | Conditions: Raynaud Disease | Phase 3 | Status: UNKNOWN